Announcements Trials
Browse Landscape

Phase

Phase 3 2Phase 2 2Phase NA 1

Status

Terminated 1Completed 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Thoracic 1

Conditions

Peripheral Sensory Neuropathy 1Neoplasms 1Carcinoma, Non-Small-Cell Lung 1

Interventions

Cisplatin 726Carboplatin 609Paclitaxel 579Cyclophosphamide 516Radiotherapy 511Docetaxel 477Fluorouracil 454Gemcitabine 438Doxorubicin 383Capecitabine 362Dexamethasone 328Oxaliplatin 289pembrolizumab 283Leucovorin 283Bevacizumab 275Etoposide 272Vincristine 270Rituximab 246Prednisone 223Pemetrexed 217Cytarabine 205Drug Therapy 194Trastuzumab 176Irinotecan 174Methotrexate 171Lenalidomide 137Nivolumab 136Filgrastim 135Epirubicin 129Tamoxifen 128

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 3 × Acetylcarnitine × Clear all
NCT01379976 2015-04-24

Acetyl-L-carnitine in Combination With a Cisplatin-containing Chemotherapy as First Line Treatment of Advanced or Metastatic Non Small Cell Lung Cancer

Mario Negri Institute for Pharmacological Research

Phase 3 Terminated
107 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung, Neoplasms

NCT01526564 2013-11-11

Clinical Study on Acetyl-L-Carnitine

Lee's Pharmaceutical Limited

Phase 3 Completed
239 enrolled

Peripheral Sensory Neuropathy

Data powered by HemOnc (CC BY 4.0) Colophon âš¡